|
|
Article: Appointments And Advancements.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ambrx Inc., of San Diego, appointed Kevin Eastwood vice president of corporate development.
Antigenics Inc., of New York, appointed Shalini Sharp chief financial officer and vice president.
Aradigm Corp., of Hayward, Calif., appointed Igor Gonda president and CEO.
Argolyn Bioscience Inc., of North Charleston, S.C., appointed James McNab executive chairman, Seth Finklestein interim chief medical officer and Eyal Ron interim director of drug development.
Arpida Ltd., of Basel, Switzerland, appointed Jurgen Raths to its board.
ArQule Inc., of Woburn, Mass., appointed Nigel Rulewski chief medical officer.
AtheroGenics ...